Beyond Air (XAIR) announced that the LungFit PH has received market authorization from the Australian Therapeutic Goods Administration for sale as a Class IIb medical device to deliver nitric oxide, a vasodilator, generated by the device into the inspiratory limb of the patient breathing circuit of a ventilator in a way that provides a constant concentration of nitric oxide, as set by the user, to the patient throughout the inspired breath.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XAIR:
Questions or Comments about the article? Write to editor@tipranks.com